Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-029516
Filing Date
2019-06-03
Accepted
2019-06-03 17:23:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv522593_s3.htm S-3 371465
2 EXHIBIT 5.1 tv522593_ex5-1.htm EX-5.1 32592
3 EXHIBIT 23.1 tv522593_ex23-1.htm EX-23.1 1900
4 GRAPHIC tv522593_ex5-1img1.jpg GRAPHIC 2970
  Complete submission text file 0001144204-19-029516.txt   411301
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231923 | Film No.: 19874369
SIC: 2834 Pharmaceutical Preparations